Ken Alltucker

Eli Lilly on May 21 said its experimental weight-loss shot retatrutide delivered dramatic weight loss in a late-stage study of people with obesity.

CVS sued Tennessee state officials on May 22 to block legislation the pharmacy giant said would force the closure of the chain's 136 Tennessee pharmacy locations.

Eli Lilly's experimental weight-loss shot, retatrutide, showed dramatic results, with some losing up to 28% of body weight.

The expiration of the Affordable Care Act's enhanced subsidies left millions of Americans who wanted to keep their insurance in 2026 with a costly choice. Stick with their mid-tier silver plan and pay a pricier monthly bill or downgrade to cheaper coverage.

Eli Lilly's experimental weight-loss shot, retatrutide, showed dramatic results, with some losing up to 28% of body weight.

CVS sued Tennessee after Gov. Bill Lee signed legislation to prohibit companies from owning both pharmacy benefit managers and retail pharmacies.

Lilly said people on the next-generation weight loss medication across three different dosages achieved weight loss of 19% to 28%.

CVS Health will reinstate coverage of Eli Lilly's weight-loss injectable Zepbound and begin coverage of the anti-obesity pill Foundayo.

UnitedHealthcare vowed to cut down two-thirds of prior approval requirements by the end of 2026 for children the health insurance giant covers.

Lucy Liu shares how a misdiagnosis led to surgery and changed how she advocates for her own health.